Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Amalgam Rx logo — Enabling better healthcare decisions. In the provider workfl...

Amalgam Rx

Enabling better healthcare decisions. In the provider workflow. In patients’ everyday lives.

Founded 2016 United States Wilmington, United States 56 employees Series B Total: $18.59M Biotechnology, Health Care +4

General Information

Company Name Amalgam Rx
Founded Year 2016
Location United States Wilmington, United States
Founders / Decision Makers
Team member
Employees 56
Industries Biotechnology, Health Care, Information Technology +3
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Amalgam Rx. To contact Amalgam Rx, visit amalgamrx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Amalgam Rx compare?

A PDF of Amalgam Rx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Amalgam Rx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Amalgam Rx

Amalgam Rx is a US-based startup founded in 2016, which operates within the Biotechnology, Health Care, and Information Technology industries. The company's slogan, "Enabling better healthcare decisions. In the provider workflow. In patients’ everyday lives," encapsulates its mission to facilitate optimal decision-making for both healthcare providers and patients. Amalgam Rx achieves this through its suite of EHR Solutions and a modular SaMD platform, catering to leading life sciences companies, health plans, and provider organizations. Notably, its algorithms and applications currently support nearly 10 million patients across 4 continents, with a track record of aiding providers in over 50 million decisions. The most recent milestone for Amalgam Rx is the Series B investment it secured on 05 October 2023, with CVS Health as the investor. This investment attests to the confidence of a major industry player in Amalgam Rx's potential and innovative approach to improving healthcare through advanced technology and data-driven solutions. In conclusion, with its regulated digital products, EHR solutions, and a wealth of real-world evidence (10 billion RWE data points), Amalgam Rx demonstrates its commitment to engaging patients and providers, ultimately contributing to enhanced healthcare decision-making globally. For more details, interested parties can visit amalgamrx.com.

Business keywords: Healthcare decision-making, EHR Solutions, SaMD platform, Life sciences companies, Health plans, Provider organizations, Regulated digital products, RWE data points, Patient engagement, Provider workflow optimization

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Undisclosed 1
CVS Health
CVS Health
05 Oct 2023
Series A $17.37M 1
Novo Nordisk
Novo Nordisk
03 Jan 2023
Seed Round $1.22M 1
Mentors Fund
Mentors Fund
16 Jun 2017

Amalgam Rx Alternatives & Competitors

View All Alternatives
Amalgam Rx vs
Dorsata
Dorsata United States

A great EHR experience for Ob-Gyns. Real-world data for Life Sciences.

Series A
17 employees
Health Care, IT
Compare Amalgam Rx vs Dorsata
Amalgam Rx vs
Orbita
Orbita United States

Orbita powers virtual health assistants that help healthcare orgs engage patients, improve outcomes,...

Series A
43 employees
AI, Health Care
Compare Amalgam Rx vs Orbita
Amalgam Rx vs
Xealth
Xealth United States

Digital health tools, ordered and delivered from the EHR workflow. Digital health at scale.

Venture round
66 employees
Analytics, Data Analytics
Also compare with: Amalgam Rx vs Dawn Health Dawn Health View all alternatives

FAQ About Amalgam Rx

Enabling better healthcare decisions. In the provider workflow. In patients’ everyday lives.
Amalgam Rx was founded in 2016.
Amalgam Rx is headquartered in Wilmington, United States.
Amalgam Rx operates in Biotechnology, Health Care, Information Technology, Life Sciences, Medical Devices and CRM and Sales. Its work centres on Healthcare decision-making, EHR Solutions, SaMD platform and Life sciences companies.
Amalgam Rx has approximately 56 employees.
Amalgam Rx has completed 3 funding rounds, raising a total of $18.59M. The latest funding stage is Series B.
Top alternatives and competitors to Amalgam Rx include Dorsata, Orbita, Xealth, Updox by EverHealth, Truveta. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amalgam Rx and Dorsata are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Amalgam Rx, https://bouncewatch.com/company/amalgam-rx, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout